Lehigh Valley Institute for Surgical Excellence and Lehigh Valley Topper Cancer Institute are the first in Pennsylvania to offer this groundbreaking treatment. For you, the patient, that means no blade, no scar and no radiation. It also means less time away from work and leisure activities.
High-intensity focused ultrasound is a noninvasive and effective option for prostate ablation that has been approved by the Food and Drug Administration for use in the U.S. since 2015.
Offering a low occurrence of side effects, it uses an ultrasound probe to scan your prostate and deliver high-intensity sound waves to a targeted area – similar to how a magnifying glass can focus light rays to burn a leaf.
The probe is inserted into the rectum and doesn’t require an incision. The magnitude of ultrasound energy delivered rapidly raises the temperature at the focal point, causing cell damage and cell death, without damaging healthy tissue and structures outside the targeted area.
You get:
- Quality of life preservation
- Low risk of side effects such as incontinence or erectile dysfunction
- Precise robotic targeting of prostate tissue with real-time ultrasound monitoring
- Less time away from work and leisure activity
You’re typically discharged shortly after the procedure, but it will be necessary for someone to accompany you because the procedure is conducted under general or spinal anesthesia.
Your urologist can determine if Focal One is the right treatment for you. Request an appointment online today or by calling 610-402-6986.
Lehigh Valley Institute for Surgical Excellence
Our surgeons have unmatched surgical expertise, including less-invasive techniques that help you heal faster.
Lehigh Valley Topper Cancer Institute
When it comes to outstanding cancer care, you have a partner in Lehigh Valley Topper Cancer Institute.